Page last updated: 2024-10-30

mesalamine and Beryllium Disease

mesalamine has been researched along with Beryllium Disease in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Beryllium Disease: Disease resulting from exposure to beryllium. Entry into the body is not limited to the inhalation route.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Day, BJ2
Huang, J1
Barkes, BQ1
Gillespie, M1
Li, L1
Maier, LA2
Dobis, DR1
Sawyer, RT1
Gillespie, MM1
Newman, LS1

Trials

1 trial available for mesalamine and Beryllium Disease

ArticleYear
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Lung, 2018, Volume: 196, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Berylliosis; Bronchoalveolar Lavage Fluid; Cell Proli

2018

Other Studies

1 other study available for mesalamine and Beryllium Disease

ArticleYear
Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
    American journal of respiratory cell and molecular biology, 2010, Volume: 43, Issue:4

    Topics: Adult; Antigen-Presenting Cells; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; Cell Prolifer

2010